Rafael Holdings IncNYSE:RFL
- LAST PRICE1.6823
- TODAY'S CHANGE (%)-0.0277 (-1.6199%)
- Bid / Lots1.6800/ 50
- Ask / Lots1.7100/ 21
- Open / Previous Close1.6900 / 1.7100
- Day Range
- 52 Week Range
- Volume3,526
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RFL |
|---|---|---|
| 09:32 ET | 826 | 1.69 |
| 09:36 ET | 448 | 1.71 |
| 10:08 ET | 175 | 1.695 |
| 10:17 ET | 1721 | 1.6823 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Rafael Holdings Inc | 42.0M | 19.3x | --- |
Palmetto Real Estate Trust | 13.3M | 27.6x | +3.53% |
Presidential Realty Corp | 76.0K | 3.7x | --- |
Power REIT | 1.7M | -0.1x | --- |
Medalist Diversified Reit Inc | 12.5M | -2.7x | --- |
Pillarstone Capital REIT | 9.9K | 0.0x | --- |
Company Information
Rafael Holdings, Inc. is a holding company with interests in clinical and early-stage pharmaceutical companies. The Company's segments include healthcare and real estate. The Company's investments include Cornerstone Pharmaceuticals, Inc., which is a cancer metabolism-based therapeutics company; LipoMedix Pharmaceuticals Ltd., which is a clinical-stage pharmaceutical company; Barer Institute Inc., which is a preclinical cancer metabolism research operation; Cyclo Therapeutics Inc., which is a clinical-stage biotechnology company dedicated to developing medicines for patients and families living with diseases through its therapeutic asset like Trappsol and Cyclo; Day Three Labs, Inc., which offers pharmaceutical-grade technology like Unlokt, and Rafael Medical Devices, LLC, which is an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries. Its real estate segment comprises of a portion of a commercial building in Israel.
Contact Information
- Headquarters
- 520 Broad StNEWARK, NJ, United States 07120
- Phone
- 212-658-1450
- Fax
- 302-636-5454
Executives
- Executive Chairman of the Board
- Howard Jonas
- President, Chief Executive Officer
- William Conkling
- Chief Financial Officer
- David Polinsky
- Chief Medical Officer
- John Goldberg
- Lead Independent Director
- Stephen Greenberg
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $42.0M |
|---|---|
Revenue (TTM) | $275.0K |
Shares Outstanding | 24.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.25 |
EPS | $0.09 |
Book Value | $4.13 |
P/E Ratio | 19.3x |
Price/Sales (TTM) | 152.9 |
Price/Cash Flow (TTM) | 16.0x |
Operating Margin | -4,729.82% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
